In the past six months, Freshpet's stock price was influenced by several key events: The company held its Q1 2026 earnings conference call on May 6, 2026, and participated in the Deutsche Bank Global Consumer Conference on June 2, 2026, followed by its Annual General Meeting on June 10, 2026. The Q2 2026 earnings conference call on August 5, 2026, reported double-digit net sales growth and margin expansion, leading to raised full-year guidance, with net sales up approximately 15.5% on about 15.7% volume growth. Freshpet also participated in the Barclays 19th Annual Global Consumer Conference on September 10, 2026. In October 2026, Needham initiated coverage with a Hold rating, while BofA maintained a Hold/Neutral rating but trimmed its target to $70 from $72, and Wells Fargo cut its target to $77 from $82 while staying Overweight. On November 4, 2026, Freshpet reported strong Q3 2026 results, with net sales of $317.8 million, up 10% year-over-year driven entirely by volume, and adjusted gross margin reached 50.0%, its highest in over seven years; the company raised its full-year 2026 net sales growth outlook to 12%-13% and adjusted EBITDA guidance to $215 million-$220 million, though the stock saw a muted market reaction. Following Q3 results, JP Morgan maintained an Overweight rating and raised its price target to $78 from $76, and Wells Fargo also maintained Overweight and raised its price target to $84 from $77. Throughout this period, investors focused on Freshpet's elevated valuation (around 34x-37x forward earnings) and weak free cash flow margins, with analysts questioning if high multiples are justified amidst rising bond yields and a shift away from richly valued growth-oriented staples.